EWTX
Edgewise Therapeutics
$39.17
−$0.14 (−0.36%)Oct 26, 2026
Key metrics
The numbers that frame EWTX today
- Market cap
- $4.25B
- ROIC
- -43%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $15.02
- 52wk High
- $48.51
Growth
Revenue and earnings trend for EWTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about EWTX
Is Edgewise Therapeutics a good buy?
Hold. Edgewise Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Edgewise Therapeutics is selling at a high price.
What is the market capitalization of EWTX?
Edgewise Therapeutics's market capitalization is $4.25B.
What is the 52-week high for EWTX stock?
The 52-week high for Edgewise Therapeutics is $48.51. The current close of $39.17 is 19.3% below that high.
What is the 52-week low for EWTX stock?
The 52-week low for Edgewise Therapeutics is $15.02. The current close of $39.17 is 160.8% above that low.
Does EWTX stock pay dividends?
Edgewise Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EWTX?
Edgewise Therapeutics's Debt / Equity ratio is 0.01.